October 18, 2018 Noon – 5pm
Research shows those early stage companies that leverage boards and advisors early in their development accelerate faster and outperform those companies that don’t.
We aim to make sure you are part of the success league!
If you are a CEO of an early stage company, an investor who aspires to offer expertise as an advisor or board director, or a mentor who wishes to consider governance roles, this workshop is for you!
You are invited to attend this vital program designed to help new CEOs of early stage companies with the best governance and advisory support for success.
Studies show a critical factor for long-term success rests with how well the CEO takes full advantage of its board, advisory board and direct professional executive coaching.This is especially true in the first year. CEOs are winners in building viable companies when they:
This half-day program introduces methods, tactics, policies, and best practices CEOs can use to leverage the full potential of the combined talent to build a viable enterprise.This dynamic, interactive and robust program includes the following topics:
CEOs, Governance & The Big Picture
Board Simulation: Try It On
Advisory Boards: Fast Lane Learning
Professional Growth in Leadership
Donna is CEO and Board Director of Boardwise., Inc. as well as Chairperson of Hamlin Harkins, Ltd., a 35 year-old international management consulting firm working with a broad spectrum of domestic and international companies on issues of strategy, market growth and performance improvement. Industries served are wide, including: high technology, retail, professional services, finance and manufacturing spanning 42 countries.
Boardwise, Inc. provides global clients with a combination of professional services and best-in-class software solutions related to corporate governance, including, training, professional certification, director assessment, research, board evaluation and an established first-ever global registry of qualified directors. Clients include a broad range of industries, including global corporations such as ING Bank and an exclusive contract to conduct board evaluations for all publicly listed companies in China.
Founding Boardwise. Inc. as CEO in 2010,Donna took it from start-up to a multinational organization in 3 years. Simultaneously, she continued as Board Chair for Hamlin Harkins, Ltd., which holds a long history of awards for corporate success, including ones from General Electric and the International Communication Association.
In addition to her current board and executive roles, Donna’s board experience includes serving as: Director of Dailypay, Inc, Director for Interhealth, USA, a leading international provider of nutraceuticals, including chair of the compensation committee; board advisory member for Paramit Corporation, a fast-growing standards-setting electronic contract manufacturer as well as for: CoreBrand, a privately-held advertising and branding firm in New York; Lead-Women, an executive development firm in Malaysia; and Themyscira Institute for Integrative Leadership in Europe and has been as a director for the San Jose Stage Company for 25 years. She also served as advisor to compensation committees for publicly-held companies: Asyst Technologies and Trident Microsystems.
Prior to these roles, she served as board director for Commonwealth Central Credit Union, CardioGrade, Inc., Agromac International, and for the non-profit organizations: Girls, Inc, United Way, and the San Jose Ballet.
Donna holds professional governance certifications from National Association of Corporate Directors and Harvard University. She is recognized for her board style as a statesman, with an ability to successfully facilitate robust discussions of issues and integrate directors’ thinking into creative solutions.
Donna holds a Ph.D. in strategic planning from Rensselaer Polytechnic Institute(RPI), an M.S. with honors in organizational communication also from RPI, and a B.A. from Siena College.
Nola Masterson works with our clients on governance practices and coaches directors and aspirational directors. She is an experienced global executive and board leader serving on public companies, venture-backed private companies and non- profit organization boards. Her successful business experience, as CEO and co- founder of Sequenom, (SQNM) and the first analyst in biotechnology on Wall Street with Drexel Burnham Lambert and Merrill Lynch, followed successful business building at Millipore for eightyears.She has managed her own venture fund, as well as been a Venture Partner in a major European IT and life sciences venture fund, TVM Capital. During her 15 years on the Repros Therapeutics (RPRX) Board as Chair of the Board and Compensation Committee she advised the CEO on strategy, finance, operations, and board recruitment.
Areas of expertise include medical device, pharmaceuticals, scientific tools, separation processes and diagnostics technology as well as genetic analysis. One strength she brings is her understanding of the “DNA” that makes a company great. Her leadership style is as a synthesizer, to createa professionalenvironment that aligns with, and contributes to success at every stage of company development.Ms. Masterson is certified by the American College of Corporate Directors as an Advanced Certified ProfessionalDirector and is listed in the Boardwise Registry of Corporate Directors. She has attended The Stanford Board Development Program and the Harvard Business School Program. She has solidexperience in board position recruitment and transition processes, in building productive board cultures and aligning these with CEOs and senior executive accountabilities.
She started her own venture fund in 1998.As a venture investor, she served on the Board of EpiCept Corporation, which focused on vascular disruptive agents, and on the Board of Nanostream, Inc., a venture- backed company focused on assay detection, liquid chromatography, and sample preparation. She served on the Board of Omicia, Inc, now called Fabric Genomics, a genomics translation company for 7 years. Her experience as CEO of Sequenom helped her understand NGS, and the software needed to support its translation to medicine. She is the Managing Director of Science Futures Management Company and works as an advisor, board member and investor. She also serves on the Board ofResonance-med.com in Chicago and Zivo Biosciences, (ZIVO) a public company headquartered in Detroit MI.She also has served on the Board of Generex Biotechnology Corporation, a Toronto, Canada based publicly-traded (NASDAQ: GNBT) company focused on the development of drug delivery systems and antigen technologies, and served on the Audit, and Compensation Committee and Chaired the Nomination And Governance Committee of the Generex Board. She is a special advisor to several private companies and is Chair Emeritus of the BayBio Institute, a best-practices and workforce development arm of the Northern California life sciences industry association.
Currently she is an Adjunct Professor at University of San Francisco in the School of Business Management, teaching the Business of Biotech. She lectures and writes for the Life Science Foundation. She also serves on the Silicon Valley Chapter Board of the American Diabetes Association. She is co-chair of the San Francisco Chapter of the Women Corporate Director.
This Boardwise program is free of charge for our Global Governance Members. If you are a member, use code WINGUEST!. The fee for non-members is $40. Enroll soon to reserve your place!
Date: October 18, 2018
Time: Noon - 5pm
Main Schedule: Noon – 1:00, Registration and Lunch, 1:00 - 5:00 Program, 5:00 - 6:00 Cocktails and Networking
Location: DLA Piper Offices at 2000 University AvePalo Alto, CA
For more information, contact: email@example.com